What is BTIG's price target for MRSN?

BTIG's latest stated price target for Mersana Therapeutics Inc. (MRSN) is $6, from its action on Feb 29, 2024.

What is BTIG's rating on MRSN?

BTIG rates MRSN Buy, a bullish rating, as of Feb 29, 2024.

When did BTIG last change its view on MRSN?

On Feb 29, 2024, BTIG upgrades to Buy from Neutral, price target $6.

BTIG MRSN price target and rating history

Mersana Therapeutics Inc. (MRSN) · Health Care

BTIG rates Mersana Therapeutics Inc. (MRSN) Buy with a $6 price target, as of its latest action on Feb 29, 2024. It has published 3 rating actions on MRSN since October 2021, including 1 upgrade and 1 downgrade.

Current rating: Buy
Price target: $6
Median target, all firms: Too few
Actions on MRSN: 3

BTIG price target on MRSN

BTIG price target on MRSN, each point a stated target, October 2021 to February 2024.

Every BTIG rating on MRSN

Feb 29, 2024
UpgradeBTIG upgrades to Buy from Neutral, price target $6
Jul 27, 2023
DowngradeBTIG downgrades to Neutral from Buy
Oct 15, 2021
ResumeBTIG resumes coverage at Buy, price target $32

Questions about BTIG and MRSN

What is BTIG's price target for MRSN?: BTIG's latest stated price target for Mersana Therapeutics Inc. (MRSN) is $6, from its action on Feb 29, 2024.
What is BTIG's rating on MRSN?: BTIG rates MRSN Buy, a bullish rating, as of Feb 29, 2024.
When did BTIG last change its view on MRSN?: On Feb 29, 2024, BTIG upgrades to Buy from Neutral, price target $6.

More MRSN rating histories

All BTIG ratings MRSN news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.